TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7006303

Group type: EXPERIMENTAL
Intervention: Atropine (0.25 mg or 0.50 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low dosage atropine (0.25 mg)
Number of subjects: 60
Study: 30612163

Group type: EXPERIMENTAL
Intervention: High-intensity resistance and impact training (HiRIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unsupervised, low-intensity, home-based exercise)
Number of subjects: 0
Study: 28581920

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Ca(OH)2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both Ca(OH)2 and MTA
Number of subjects: 100
Study: 26406065

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 23961833

Group type: EXPERIMENTAL
Intervention: OM-plus-RMC
Number of subjects: 446

Group type: COMPARATOR
Intervention: OM-only
Number of subjects: 446
Study: 21876310

Group type: EXPERIMENTAL
Intervention: Cloxacillin (100 mg/mL) plus heparin (1000 IU/mL) as a 2.5-mL solution instilled in each catheter lumen after dialysis session
Number of subjects: 100

Group type: COMPARATOR
Intervention: Heparin only
Number of subjects: 100
Study: 19626504

Group type: EXPERIMENTAL
Intervention: Having a regular doctor
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Having a physical in the last year
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Previous physician recommendation for testing
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Asking a physician for testing
Number of subjects: 1532

Group type: COMPARATOR
Intervention: Regular doctor being a Vietnamese man
Number of subjects: 1532
Study: 17440795

Group type: EXPERIMENTAL
Intervention: Laparoscopic TAPP
Number of subjects: 867

Group type: COMPARATOR
Intervention: Shouldice repair
Number of subjects: 867
Study: 15502037

Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 40
Study: 11922403

Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Perindopril 2 mg
Number of subjects: 240
Study: 9931709

Group type: EXPERIMENTAL
Intervention: Chemotherapy with cisplatinum, 5-FU and leucovorin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Etoposide, adriamycin and cisplatinum (EAP)
Number of subjects: 41
Study: 8110556

Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine (loading dose 140 micrograms, followed by 5 micrograms h‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3339788

Group type: EXPERIMENTAL
Intervention: Lidocaine (dorsal penile nerve block)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 60
Study: 31775402

Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other techniques
Number of subjects: 0
Study: 28435117

Group type: EXPERIMENTAL
Intervention: Direct continuous ICP monitoring
Number of subjects: 30
Study: 25130061

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LSM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (not randomized to LSM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HIV-infected subjects (all)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HIV-infected subjects
Number of subjects: 50
Study: 24330906

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) delivered at 1-3 mA current intensity for 20-30 minutes in once- to twice-daily sessions for up to 3 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 21745622

Group type: EXPERIMENTAL
Intervention: 0.5% PL
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1% PL
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.5% PL (elderly participants)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1% PL (elderly participants)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (elderly participants)
Number of subjects: 75
Study: 19423455

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus low molecular weight heparin (LMWH) treatment (LT group, n = 135)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Conventional treatment (C group, n = 130)
Number of subjects: 265
Study: 17036233

Group type: EXPERIMENTAL
Intervention: Neurological insoles
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo insole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Convenient shoes without insoles
Number of subjects: 20

Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 20
Study: 15001678

Group type: EXPERIMENTAL
Intervention: SPECT imaging with (99m)Tc‐TRODAT‐1
Number of subjects: 78
Study: 11520387

Group type: EXPERIMENTAL
Intervention: Practice exercise with a single curve
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group with two survival curves
Number of subjects: 246
Study: 9684794

Group type: EXPERIMENTAL
Intervention: SILIMAT APTT reagent
Number of subjects: 170

Group type: COMPARATOR
Intervention: Automated APTT (Organon‐Teknika)
Number of subjects: 170
Study: 7831140

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg oral midazolam
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 31
Study: 3365924

Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 10 mL of sterile water for injection
Number of subjects: 10

Group type: COMPARATOR
Intervention: Minibag system
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 20 mL of D5NS as the diluent
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 10 mL of 5% dextrose and 0.9% sodium chloride injection (D5NS)
Number of subjects: 10
Study: 30100096

Group type: EXPERIMENTAL
Intervention: Physical therapy for low back pain with or without manual therapy and exercise directed at the femoroacetabular joints
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Having a concurrent hip problem
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lower body mass index ≤25.4
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Irritable condition
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Baseline NPRS score of 4 points or less
Number of subjects: 90
Study: 26959198

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg, n=615)
Number of subjects: 1228

Group type: COMPARATOR
Intervention: Placebo (n=613)
Number of subjects: 1228
Study: 25575220

Group type: EXPERIMENTAL
Intervention: ReJoyce Arm and Hand Function Test (RAHFT)
Number of subjects: 13
Study: 23010882

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 100 mg/day
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study: 20859299

Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) 400 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18060999

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment for atrial fibrillation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical or pharmacologic cardioversion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy
Number of subjects: 0
Study: 12056783

Group type: EXPERIMENTAL
Intervention: Nutritional regimen with insulin-like growth factor-1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nutritional regimen with transthyretin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nutritional regimen with retinol binding protein
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nitrogen balance
Number of subjects: 24
Study: 9793770

Group type: COMPARATOR
Intervention: OBF tonograph version 8.2
Number of subjects: 194

Group type: COMPARATOR
Intervention: OBF tonograph version 11.2
Number of subjects: 194
Study: 8080680

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (cyclophosphamide, doxorubicin, 5‐fluorouracil)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy after primary irradiation +/‐ surgery
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 414

Group type: COMPARATOR
Intervention: Primary irradiation (55 Gy)
Number of subjects: 414
Study: 2925456

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g, intravenous administration, 30 to 60 minutes preoperatively)
Number of subjects: 103
Study: 923513

Group type: EXPERIMENTAL
Intervention: EMG feedback
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alpha feedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Joked control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study: 28488911

Group type: EXPERIMENTAL
Intervention: Video-Assisted Lateral Neck Dissection (VALND)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open Lateral Neck Dissection (LND)
Number of subjects: 64
Study: 26192876

Group type: EXPERIMENTAL
Intervention: Kisspeptin-54 (3.2 nmol/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kisspeptin-54 (6.4 nmol/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kisspeptin-54 (9.6 nmol/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kisspeptin-54 (12.8 nmol/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (standard recombinant FSH/GnRH antagonist protocol)
Number of subjects: 60
Study: 22336429

Group type: EXPERIMENTAL
Intervention: Primary vitrectomy (PV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scleral buckling surgery (SB)
Number of subjects: 0
Study: 21995514

Group type: EXPERIMENTAL
Intervention: Culturally focused psychiatric (CFP) consultation including toolkits with psychoeducational booklets, worksheets, and community resources.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 19204654

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day for 8 weeks, then up to 120 mg/day for 6 months
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg/day for 8 weeks, then up to 20 mg/day for 6 months
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 547
Study: 16766343

Group type: EXPERIMENTAL
Intervention: Coherence judgment task (n = 39)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Word recognition paradigm (n = 60)
Number of subjects: 99
Study: 15611423

Group type: EXPERIMENTAL
Intervention: Oral PUVA using methoxsalen capsules and a portable tanning unit at home
Number of subjects: 158

Group type: COMPARATOR
Intervention: Hospital-administered bath PUVA with trioxsalen
Number of subjects: 158
Study: 11452078

Group type: EXPERIMENTAL
Intervention: Computer-based cases with interactive elements
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Computer-based cases without interactive elements
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Paper-based cases with interactive elements
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (not exposed to cases)
Number of subjects: 225
Study: 9210005

Group type: EXPERIMENTAL
Intervention: Cefepime 1 g b.i.d.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Ceftazidime 1 g t.i.d.
Number of subjects: 86
Study: 8223735

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise stress test (CPX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard ECG exercise stress test (CX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blood lactate kinetics analysis
Number of subjects: 40
Study: 30657971

Group type: EXPERIMENTAL
Intervention: Parent-collected nasal swab
Number of subjects: 64

Group type: COMPARATOR
Intervention: Healthcare worker-collected nasopharyngeal swab
Number of subjects: 64
Study: 29781558

Group type: EXPERIMENTAL
Intervention: High-risk group (n=218)
Number of subjects: 1777

Group type: EXPERIMENTAL
Intervention: Logistic regression model including clinical variables
Number of subjects: 1777
Study: 27795779

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% (1 ml/kg) with fentanyl 1 μg/kg and clonidine 1μg/kg (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: bupivacaine 0.25% (1 ml/kg) with fentanyl 1 μg/kg (group II)
Number of subjects: 40
Study: 24876164

Group type: EXPERIMENTAL
Intervention: PhotoDyn(®) 750 (PD750), 580‐1400 nm for 30 min
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waldmann(®) 1200L (Wa1200L), 600‐720 nm for 10‐11 min
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PhotoDyn(®) 750 (PD750)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waldmann(®) 1200L (Wa1200L)
Number of subjects: 88
Study: 23210419

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate whitening dentifrice (Arm & Hammer Advance White Extreme Whitening Baking Soda and Peroxide Toothpaste)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Negative control dentifrice (silica-based)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Continued use of whitening dentifrice for an additional two weeks
Number of subjects: 146

Group type: COMPARATOR
Intervention: Switched to negative control dentifrice for an additional two weeks
Number of subjects: 146
Study: 20151972

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1327
Study: 19224787

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 112
Study: 16859179

Group type: EXPERIMENTAL
Intervention: Acacia colei seed flour at 25% (w/w)
Number of subjects: 118

Group type: COMPARATOR
Intervention: All diets (including control)
Number of subjects: 118
Study: 12558762

Group type: EXPERIMENTAL
Intervention: Hemodialysis treatment
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Beginning of the dialysis program
Number of subjects: 123
Study: 10865162

Group type: EXPERIMENTAL
Intervention: Barrier-specific telephone counseling (BSTC)
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Physician-based educational intervention (MD-ED)
Number of subjects: 1655

Group type: COMPARATOR
Intervention: Reminder control (RC)
Number of subjects: 1655
Study: 9410299

Group type: EXPERIMENTAL
Intervention: Budesonide (Pulmicort and Horacort) 640 mg or 800 mg daily for 6 weeks
Number of subjects: 55
Study: 8408569

Group type: EXPERIMENTAL
Intervention: High-titer vaccine (10^6 PFU)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Low-titer vaccine (10^5 PFU)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 3609883

Group type: EXPERIMENTAL
Intervention: Flunarizine (5 mg once daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31353941

Group type: EXPERIMENTAL
Intervention: Scapular exercise programme plus physical therapy treatment
Number of subjects: 102

Group type: COMPARATOR
Intervention: Physical therapy treatment
Number of subjects: 102
Study: 29931835

Group type: EXPERIMENTAL
Intervention: Active rTMS (1 Hz, right dorsolateral prefrontal cortex)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 31
Study: 26704923

Group type: EXPERIMENTAL
Intervention: 80 μg/day Vitamin D3 dissolved in oil
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (pure oil)
Number of subjects: 94
Study: 24878214

Group type: EXPERIMENTAL
Intervention: Grip on Challenging Behavior care program
Number of subjects: 659

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 659
Study: 23328380

Group type: EXPERIMENTAL
Intervention: GlideScope (G)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fiberoptic bronchoscope (F)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of GlideScope and fiberoptic bronchoscope (G+F)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (G, F, G+F)
Number of subjects: 90
Study: 19706002

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study: 18663331

Group type: EXPERIMENTAL
Intervention: Monthly dietetic consultations for 6 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care with dietetic consultations every 6 months
Number of subjects: 67
Study: 16189970

Group type: EXPERIMENTAL
Intervention: New three-dimensional image processing technique for PET
Number of subjects: 12
Study: 11832363

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (TE) injections (n=7)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n=5)
Number of subjects: 12
Study: 10394114

Group type: EXPERIMENTAL
Intervention: Supplemented hypokinetic subjects (SHKS) taking daily 23 mg Mg as Mg lactate per kilogram body weight
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Unsupplemented hypokinetic subjects (UHKS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supplemented ambulatory control subjects (SACS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unsupplemented ambulatory control (UACS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Supplemented hypokinetic subjects (SHKS)
Number of subjects: 40
Study: 7574861

Group type: EXPERIMENTAL
Intervention: Extended release felodipine
Number of subjects: 21
Study: 2344752

Group type: EXPERIMENTAL
Intervention: Kinetic Treatment Table (KTT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional bed care
Number of subjects: 49
Study: 6108449

Group type: EXPERIMENTAL
Intervention: Intravenous aminoacids (70‐85 g daily in the form of 'Aminosyn' or 'Travasol')
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no aminoacid therapy)
Number of subjects: 35
Study: 31842936

Group type: EXPERIMENTAL
Intervention: FES‐CE‐based intensified rehabilitation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 150
Study: 27825914

Group type: EXPERIMENTAL
Intervention: Flexible Policy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Policy
Number of subjects: 0
Study: 25818925

Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 23652751

Group type: EXPERIMENTAL
Intervention: Etoricoxib treatment
Number of subjects: 205
Study: 21384391

Group type: EXPERIMENTAL
Intervention: Q-switched Alexandrite laser (50 nanoseconds)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-pulsed Alexandrite laser (100 microseconds)
Number of subjects: 20
Study: 19152069

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 17288990

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET), 5 sessions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Psychoeducation (PED), 1 session
Number of subjects: 18
Study: 12614412

Group type: EXPERIMENTAL
Intervention: Ambulatory phlebectomy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Compression sclerotherapy
Number of subjects: 82
Study: 11093299

Group type: EXPERIMENTAL
Intervention: Frequency of fast food restaurant use
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Increased frequency of fast food restaurant use over 3 years
Number of subjects: 891
Study: 9433650

Group type: EXPERIMENTAL
Intervention: Single oral administration of grepafloxacin (200 to 1200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeat oral administration of grepafloxacin (400 and 800 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single and repeat doses of grepafloxacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Grepafloxacin compared to other quinolones
Number of subjects: 0
Study: 8455318

Group type: EXPERIMENTAL
Intervention: Structured triglyceride fat emulsion 73403
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intralipid 20% (control)
Number of subjects: 20
Study: 3460195

Group type: EXPERIMENTAL
Intervention: Nicotine chewing gum (2 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Menthol-tasting chewing gum
Number of subjects: 25
Study: 31482428

Group type: COMPARATOR
Intervention: Model A (clinical)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Model B (radiomic)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Model C (radiomic/clinical)
Number of subjects: 189
Study: 27933408

Group type: EXPERIMENTAL
Intervention: PRO + PRT (0.33 g/kg body mass of a milk-based protein matrix for 12 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: PRO (0.33 g/kg body mass of a milk-based protein matrix for 12 weeks)
Number of subjects: 57
Study: 25482467

Group type: EXPERIMENTAL
Intervention: Hot condition (26°C)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cold condition (19°C)
Number of subjects: 21
Study: 23726393

Group type: EXPERIMENTAL
Intervention: Early surgery (haematoma evacuation within 12 hours of randomisation) plus medical treatment
Number of subjects: 601

Group type: COMPARATOR
Intervention: Initial conservative treatment (medical treatment alone)
Number of subjects: 601
Study: 21226674

Group type: COMPARATOR
Intervention: Occupational therapy group
Number of subjects: 238

Group type: COMPARATOR
Intervention: Trained assessor group
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Environmental assessment
Number of subjects: 238
Study: 19850063

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Theory of Planned Behavior (TPB)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 599
Study: 16906087

Group type: EXPERIMENTAL
Intervention: Group I (transverse partial sacrectomy below S1 neural foramina)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Group II (transverse partial sacrectomy above S1 neural foramina)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control Group (sacrum intact)
Number of subjects: 10